Allergan, Inc.
U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany
New Jersey
07054
United States
Tel: 1 (862) 261-7000
Website: http://www.allergan.com/
About Allergan, Inc.
Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.
We’re Looking for the World’s Best
At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.
At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.
Commit to your future and join us. Learn more about our exciting career opportunities at www.allergan.com/careers.
YEAR FOUNDED:
1948
LEADERSHIP:
Founder: Gavin S. Herbert
CEO: Brenton L. Saunders
CFO: Maria Teresa Hilado
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products
1188 articles about Allergan, Inc.
-
Allergan Inc. Announces Signing Of FTC Consent Order
3/6/2006
-
Allergan Inc. Extends Expiration Date Of Inamed Corporation Exchange Offer
2/22/2006
-
Allergan Inc. Extends Expiration Date Of Inamed Corporation Exchange Offer
2/6/2006
-
Allergan Inc. Announces Promotion Of F. Michael Ball To President And Raymond Diradoorian To Executive Vice President, Global Technical Operations
2/3/2006
-
Allergan Inc. Reports Fourth Quarter Operating Results
2/2/2006
-
Allergan Inc. Announces Quarterly Conference Call
1/25/2006
-
Allergan Inc. Extends Expiration Date Of Exchange Offer For Inamed Corporation
1/23/2006
-
Allergan Inc. Receives Final Regulatory Approvals From Germany And Spain
1/17/2006
-
Allergan Inc. Granted Temporary Restraining Order In ACULAR(R) Patent Infringement Case
1/4/2006
-
Allergan Inc. And Inamed Corporation Execute Definitive Merger Agreement
12/21/2005
-
Allergan Inc. Requests Temporary Restraining Order And Preliminary Injunction In ACULAR(R) Patent Infringement Case
12/19/2005
-
Allergan Inc. Extends Expiration Date Of Exchange Offer For Inamed Corporation
12/19/2005
-
Inamed Corporation Says Board OKs Allergan Inc.'s $3.2 Billion Offer
12/15/2005
-
Inamed Corporation Receives Irrevocable Offer And Merger Agreement From Allergan Inc.
12/6/2005
-
Medicis Pharmaceutical Requests That Inamed Corporation Recommend Rejection Of Allergan Inc. Exchange Offer
11/22/2005
-
Allergan Inc. Commences Exchange Offer For Shares Of Inamed Corporation
11/21/2005
-
Allergan Inc. Makes Competing $3.2 Billion Bid For Inamed Corporation
11/15/2005
-
Discovery Partners (DPII) Announces Achievement Of Milestones In Multi-Target Drug Discovery Collaboration
10/31/2005
-
Brain Injury Association Will Honor Six Arizonans, Allergan Inc., At Desert Sky Ball Dinner-Dance In February 2006
10/26/2005
-
NPS Pharmaceuticals, Inc. To Promote Allergan Inc.'s RESTASIS(R) To Rheumatologists In The United States
10/24/2005